23 Recruiting Studies Using Bicalutamide
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Bicalutamide
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
📍 Clinical Research Facility — Homewood, Alabama
Prostatic Neoplasms
View Study & Checklist ➔Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer
📍 National Cancer Institute — Bethesda, Maryland
Prostate Adenocarcinoma
View Study & Checklist ➔Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Prostate Adenocarcinoma
View Study & Checklist ➔Ribociclib and Bicalutamide in AR+ TNBC
📍 University of Illinois Cancer Center — Chicago, Illinois
Triple Negative Breast Cancer
View Study & Checklist ➔Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Breast Neoplasm Female
View Study & Checklist ➔INTREPId (INTermediate Risk Erection PreservatIon Trial)
📍 Stamford Hospital — Stamford, Connecticut
Prostate Cancer
View Study & Checklist ➔A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
📍 Arizona Center for Cancer Care - Gilbert — Gilbert, Arizona
Prostate Cancer
View Study & Checklist ➔Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial
📍 Fairbanks Memorial Hospital — Fairbanks, Alaska
Prostate Adenocarcinoma
View Study & Checklist ➔Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
PSA Level Greater Than Two
View Study & Checklist ➔Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Prostate Adenocarcinoma
View Study & Checklist ➔Palbociclib in Combination With Bicalutamide for the Treatment of AR(+) Metastatic Breast Cancer (MBC)
📍 Memorial Sloan Kettering Cancer Center — Basking Ridge, New Jersey
Metastatic Breast Cancer (MBC)
View Study & Checklist ➔Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
📍 University of Chicago — Chicago, Illinois
Prostate Cancer
View Study & Checklist ➔Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
📍 Washington University School of Medicine — St Louis, Missouri
Prostate Cancer
View Study & Checklist ➔Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
📍 Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida
Prostate Cancer
View Study & Checklist ➔Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
📍 City of Hope Medical Center — Duarte, California
Castration-Sensitive Prostate Carcinoma
View Study & Checklist ➔Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCC
📍 UB/ Great Lakes Cancer Care — Buffalo, New York
Carcinoma, Renal Cell
View Study & Checklist ➔Bicalutamide Therapy in Young Women With NAFLD and PCOS
📍 University of California San Francisco — San Francisco, California
NAFLD
View Study & Checklist ➔Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery
📍 Houston Methodist Hospital — Houston, Texas
High-risk Prostate Cancer
View Study & Checklist ➔A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer
📍 University of Arizona Cancer Center - Prevention Research Clinic — Tucson, Arizona
Non-Muscle Invasive Bladder Urothelial Carcinoma
View Study & Checklist ➔A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
📍 London Health Sciences Centre — London, Ontario
Non-Muscle Invasive Bladder Cancer
View Study & Checklist ➔REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
📍 Emory Proton Therapy Center — Atlanta, Georgia
Recurrent Prostate Carcinoma
View Study & Checklist ➔Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Castration Levels of Testosterone
View Study & Checklist ➔Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
📍 Mount Sinai Beth Israel — New York, New York
Breast Cancer
View Study & Checklist ➔